Comparison of different techniques for evaluation of cellular immunity to SARS-CoV-2 virus

Comparison of different techniques for evaluation of cellular immunity to SARS-CoV-2 virus

Most techniques for evaluation of T-cell immunity are laborious and unsuitable for routine laboratory diagnostics, thus encouraging researchers to look for accessible and reproducible tests. The purpose of our study is to compare three methods aimed for evaluation of cellular immune response levels...

Full description

Bibliographic Details
Main Authors:	Z. E. Afridonova, A. P. Toptygina, A. V. Bogolyubova, E. L. Semikina
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2023-11-01
Series:	Медицинская иммунология
Subjects:	cellular immunity sars-cov-2 hybrid immunity breakthrough immunity elispot cytotoxic lymphocytes cd8<sup>+</sup> cells
Online Access:	https://www.mimmun.ru/mimmun/article/view/2640

Similar Items

Comparison of the humoral and cellular immunity in COVID-19 convalescents
by: Anna P. Toptygina, et al.
Published: (2022-07-01)

ELISPOT assay of the SARS-CoV-2 specific T cells immune response
by: V. V. Gerasimova, et al.
Published: (2022-12-01)

Virus-Induced CD8<sup>+</sup> T-Cell Immunity and Its Exploitation to Contain the SARS-CoV-2 Pandemic
by: Maurizio Federico
Published: (2021-08-01)

Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
by: Flavia Ferrantelli, et al.
Published: (2021-03-01)

Strong SARS-CoV-2 N-Specific CD8<sup>+</sup> T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
by: Flavia Ferrantelli, et al.
Published: (2022-02-01)

Establishment and Clinical Application of a Method for Detecting T Lymphocyte Subsets by Cellular Immunochip Technology
by: Chen C, et al.
Published: (2021-12-01)

Modulation of CD8<sup>+</sup> T Cell Responses by Radiotherapy—Current Evidence and Rationale for Combination with Immune Checkpoint Inhibitors
by: Seung Hyuck Jeon, et al.
Published: (2023-11-01)

The Trinity: Interplay among Cancer Cells, Fibroblasts, and Immune Cells in Pancreatic Cancer and Implication of CD8<sup>+</sup> T Cell-Orientated Therapy
by: Yu-Hsuan Hung, et al.
Published: (2022-04-01)

Identification of Potential SARS-CoV-2 CD8<sup>+</sup> T Cell Escape Mutants
by: Syed Faraz Ahmed, et al.
Published: (2022-03-01)

SARS-CoV-2-Specific CD8<sup>+</sup> T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
by: Flavia Ferrantelli, et al.
Published: (2023-08-01)

CD8<sup>+</sup> T Cell Senescence: Lights and Shadows in Viral Infections, Autoimmune Disorders and Cancer
by: Valentina Tedeschi, et al.
Published: (2022-03-01)

Identification of Promiscuous African Swine Fever Virus T-Cell Determinants Using a Multiple Technical Approach
by: Laia Bosch-Camós, et al.
Published: (2021-01-01)

The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
by: Esther Moga, et al.
Published: (2022-06-01)

Calorie Restriction Impairs Anti-Tumor Immune Responses in an Immunogenic Preclinical Cancer Model
by: Nguyen Tien Dung, et al.
Published: (2023-08-01)

Tackling of Immunorefractory Tumors by Targeting Alternative Immune Checkpoints
by: Dharmindra Dulal, et al.
Published: (2023-05-01)

CD8+ T-cell immune escape by SARS-CoV-2 variants of concern
by: Arnaud John Kombe Kombe, et al.
Published: (2022-10-01)

A Murine CD8<sup>+</sup> T Cell Epitope Identified in the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein
by: Jihyun Yang, et al.
Published: (2021-06-01)

Specific CD8<sup>+</sup> TCR Repertoire Recognizing Conserved Antigens of SARS-CoV-2 in Unexposed Population: A Prerequisite for Broad-Spectrum CD8<sup>+</sup> T Cell Immunity
by: Wei Hu, et al.
Published: (2021-09-01)

Systemic Blood Immune Cell Populations as Biomarkers for the Outcome of Immune Checkpoint Inhibitor Therapies
by: Carlos Hernandez, et al.
Published: (2020-03-01)

Longitudinal Analysis of SARS-CoV-2-Specific Cellular and Humoral Immune Responses and Breakthrough Infection following BNT162b2/BNT162b2/BNT162b2 and ChAdOx1/ChAdOx1/BNT162b2 Vaccination: A Prospective Cohort in Naive Healthcare Workers
by: Geon Young Ko, et al.
Published: (2023-10-01)

N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
by: Chiara Chiozzini, et al.
Published: (2020-05-01)

c-Met<sup>+</sup> Cytotoxic T Lymphocytes Exhibit Enhanced Cytotoxicity in Mice and Humans In Vitro Tumor Models
by: Mahdia Benkhoucha, et al.
Published: (2023-11-01)

T Cells Immunophenotyping and CD38 Overexpression as Hallmarks of the Severity of COVID-19 and Predictors of Patients’ Outcomes
by: Nesrin I. Tarbiah, et al.
Published: (2023-01-01)

Evaluation of Long-Term Adaptive Immune Responses Specific to SARS-CoV-2: Effect of Various Vaccination and Omicron Exposure
by: Hyunhye Kang, et al.
Published: (2024-03-01)

Ageing Curtails the Diversity and Functionality of Nascent CD8<sup>+</sup> T Cell Responses against SARS-CoV-2
by: Davide Proietto, et al.
Published: (2023-01-01)

Cellular immune response of SARS-CoV-2 vaccination in kidney transplant recipients: a systematic review and meta-analysis
by: Suwasin Udomkarnjananun, et al.
Published: (2023-07-01)

Cytomegalovirus Infection in Lung Transplantation: Importance of Specific Cellular Immune Response Assessment
by: Víctor Monforte, et al.
Published: (2023-07-01)

The Role of CD28 and CD8<sup>+</sup> T Cells in Keloid Development
by: Mengjie Shan, et al.
Published: (2022-08-01)

CD4<sup>+</sup>CD25<sup>+</sup> Cells Are Essential for Maintaining Immune Tolerance in Chickens Inoculated with Bovine Serum Albumin at the Late Stage of Embryonic Development
by: Xiaoxue Yu, et al.
Published: (2020-10-01)

Legend or Truth: Mature CD4<sup>+</sup>CD8<sup>+</sup> Double-Positive T Cells in the Periphery in Health and Disease
by: Magdalena Hagen, et al.
Published: (2023-10-01)

STAT3, a Master Regulator of Anti-Tumor Immune Response
by: Cédric Rébé, et al.
Published: (2019-08-01)

CELL-MEDIATED IMMUNITY IN PATIENTS WITH POSTTRAUMATIC LONG BONE OSTEOMYELITIS IN THE COURSE OF MANAGEMENT WITH THE ILIZAROV METHOD
by: M. V. Chepeleva, et al.
Published: (2019-02-01)

Clinical and immunological characteristic of natural course at the early stages of HIV infection
by: E. R. Manapova, et al.
Published: (2020-05-01)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
by: Arne Søraas, et al.
Published: (2022-09-01)

Long-Term Antitumor CD8<sup>+</sup> T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
by: Flavia Ferrantelli, et al.
Published: (2021-05-01)

Investigating the Prognostic Relevance of Tumor Immune Microenvironment and Immune Gene Assembly in Breast Carcinoma Subtypes
by: Beáta Szeitz, et al.
Published: (2022-04-01)

A Rapid and Simple Multiparameter Assay to Quantify Spike-Specific CD4 and CD8 T Cells after SARS-CoV-2 Vaccination: A Preliminary Report
by: Mojtaba Shekarkar Azgomi, et al.
Published: (2021-10-01)

Erratum: Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
by: Frontiers Production Office
Published: (2023-07-01)

Accumulation of CD28<sup>null</sup> Senescent T-Cells Is Associated with Poorer Outcomes in COVID19 Patients
by: Mia J. Coleman, et al.
Published: (2021-09-01)

Positive Correlation of Peripheral CD8<sup>+</sup> T Lymphocytes with Immune-Related Adverse Events and Combinational Prognostic Value in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors
by: Kan Wu, et al.
Published: (2022-07-01)